Furthermore, in a cohort of 330 patient GC tumors, our study showed that HOXB7 immuno-positivity was observed in 59.1% of GC patients and was associated with increased tumor size, depth of invasion, lymph node metastasis, distant metastasis, and TNM stage. Here, HOXB7 is linked to metastatic malignant neoplasm in the lymph nodes.